The effect of HIV infection on longitudinal lung function decline among IDUs: A prospective cohort

AIDS

Volumn 27, Issue 8, 2013, Pages 1303-1311

  Drummond, Michael Bradley ^a   Merlo, Christian A ^a   Astemborski, Jacquie ^b   Kalmin, Mariah M ^c   Kisalu, Annamarie ^b   McDyer, John F ^d   Mehta, Shruti H ^b   Brown, Robert H ^a,e   Wise, Robert A ^a   Kirk, Gregory D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e The Johns Hopkins University   (United States)

Author keywords

HIV; Lung Disease; Lung function; Obstructive; Respiratory tract disease

Indexed keywords

ADULT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SPIROMETRY; VIRUS LOAD;

ADULT; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HIV INFECTIONS; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; TIME FACTORS; VIRAL LOAD; VITAL CAPACITY;

EID: 84879122118     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835e395d     Document Type: Review

References (32)

1. Walensky RP, Paltiel AD, Losina E, Mercincavage L.M., Schackman BR, Sax PE, et al The survival benefits of AIDS treatment in the United States. J Infect Dis 2006; 194:11-19.
2. Braithwaite RS, Justice AC, Chang C.C., Fusco JS, Raffanti SR, Wong JB, et al Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005; 118:890-898.
3. Wood E, Hogg RS, Lima V.D., Kerr T., Yip B, Marshall BD, et al Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA 2008; 300:550-554.
4. Effros RB, Fletcher CV, Gebo K, Halter J.B., Hazzard WR, Horne FM, et al Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47:542-553.
5. Salter ML, Lau B, Go V.F., Mehta SH, Kirk GD HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis 2011; 53:1256-1264.
6. Shiels MS, Cole SR, Kirk G.D., Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52:611-622.
7. Barnett CF, Hsue PY, Machado RF Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. JAMA 2008; 299:324-331.
8. Fitch KV, Looby SE, Rope A, Eneh P., Hemphill L, Lee H, et al Effects of aging and smoking on carotid intima media thickness in HIV-infection. AIDS 2013; 27:49-57.
9. Crothers K, Thompson BW, Burkhardt K, Morris A., Flores SC, Diaz PT, et al HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc 2011; 8:275-281.
10. Gingo MR, George MP, Kessinger C.J., Lucht L., Rissler B, Weinman R, et al Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182:790-796.
11. Diaz PT, Clanton TL, Pacht ER Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992; 116:124-128.
12. Morris AM, Huang L, Bacchetti P., Turner J, Hopewell PC, Wallace J.M., et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. Am J Respir Crit Care Med 2000; 162:612-616.
13. Diaz PT, King MA, Pacht E.R., Wewers MD, Gadek JE, Nagaraja HN, et al Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132:369-372.
14. Crothers K, Butt AA, Gibert C.L., Rodriguez-Barradas MC, Crystal S, Justice AC Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130:1326-1333.
15. Drummond MB, Kirk GD, Astemborski J, Marshall M.M., Mehta SH, McDyer JF, et al Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012; 67:309-314.
16. Mitchell DM, Fleming J, Pinching A.J., Harris JR, Moss FM, Veale D, et al Pulmonary function in human immunodeficiency virus infection. Am Rev Respir Dis 1992; 146:745-751.
17. Vlahov D, Anthony JC, Munoz A, Margolick J., Nelson KE, Celentano DD, et al The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109:75-100.
18. Marshall MM, Kirk GD, Caporaso N.E., McCormack MC, Merlo CA, Hague JC, et al Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav 2011; 36:61-67.
19. Drummond MB, Kirk GD, Ricketts E.P., McCormack MC, Hague JC, McDyer JF, et al Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. BMC Pulm Med 2010; 10:27.
20. Drummond MB, Kirk GD, Astemborski J, McCormack M.C., Marshall MM, Mehta SH, et al Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users. Int J Chron Obstruct Pulmon Dis 2011; 6:89-95.
21. Drummond MB, Merlo C, Astemborski J., Mehta SH, Wise R, Brown RH, et al The impact of HIV infection on longitudinal lung function decline. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012, Seattle, WA. Available at www.retroconference.org
22. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279:35-40.
23. Miller MR, Hankinson J, Brusasco V., Burgos F, Casaburi R, Coates A., et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338.
24. Hankinson JL, Odencrantz JR, Fedan KB Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-187.
25. Knaupp AS, Bottomley SP Serpin polymerization and its role in disease - the molecular basis of alpha1-antitrypsin deficiency. IUBMB Life 2009; 61:1-5.
26. Zeger SL, Liang KY Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-130.
27. Drummond MB, Kirk GD, Astemborski J, Marshall M.M., Mehta SH, McDyer JF, et al Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2011.
28. Anthonisen NR, Connett JE, Murray RP Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166:675-679.
29. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-1648.
30. Brenchley JM, Schacker TW, Ruff L.E., Price DA, Taylor JH, Beilman GJ, et al CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
31. Saetta M, Turato G, Maestrelli P., Mapp CE, Fabbri LM Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1304-1309.
32. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118:3546-3556.